|
As big pharma continually struggles to identify the right strategy in order to satisfy the marketplace demands and deliver expected financial returns, one area that will always remain a priority is the business obligation to patient safety. Managing the regulatory requirement for any pharmaceutical business is a costly process, but one that cannot easily be ignored. As companies continually strive to cut costs, mostly in the form of employee cutbacks, they have to remain totally committed to satisfying the various regulatory authorities’ compliance requirements and, as this can be a resource-hungry exercise, having fewer employees can introduce some risk into their business. Managing this risk is also the key to controlling cost, and companies should have annual key strategic objectives based around how they will successfully control and improve their compliance performance, as the ever changing demands create new and often more difficult challenges. |
